OSE Immunotherapeutics
OSE.PA
#8592
Rank
C$0.19 B
Marketcap
$9.02
Share price
-1.55%
Change (1 day)
10.23%
Change (1 year)

Earnings for OSE Immunotherapeutics (OSE.PA)

Earnings in 2023: -C$35.57 Million

According to OSE Immunotherapeutics's latest financial reports the company's current earnings are C$2.46 Million. In 2023 the company made an earning of -C$35.57 Million a decrease over its 2022 earnings that were of -C$26.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for OSE Immunotherapeutics from 2012 to 2023

Annual earnings

Year Earnings Change
2023-C$35.57 Million32.79%
2022-C$26.79 Million-0.83%
2021-C$27.01 Million-17.65%
2020-C$32.8 Million1343.42%
2019-C$2.28 Million-130.46%
2018C$7.46 M-135.22%
2017-C$21.18 Million-182.62%
2016C$25.63 M-403.67%
2015-C$8.45 Million76.85%
2014-C$4.78 Million897.97%
2013-C$0.48 Million-81.82%
2012-C$2.64 Million